| Literature DB >> 26059841 |
Hirotsugu Oda1,2, Tatsuhiro Sato3, Shinji Kunishima4, Kenji Nakagawa1, Kazushi Izawa1, Eitaro Hiejima1, Tomoki Kawai1, Takahiro Yasumi1, Hiraku Doi1, Kenji Katamura1, Hironao Numabe1,5, Shinya Okamoto6,7, Hiroshi Nakase8, Atsushi Hijikata2, Osamu Ohara2,9, Hidenori Suzuki10, Hiroko Morisaki11, Takayuki Morisaki11, Hiroyuki Nunoi12, Seisuke Hattori3, Ryuta Nishikomori1, Toshio Heike1.
Abstract
Loss-of-function mutations in filamin A (FLNA) cause an X-linked dominant disorder with multiple organ involvement. Affected females present with periventricular nodular heterotopia (PVNH), cardiovascular complications, thrombocytopenia and Ehlers-Danlos syndrome. These mutations are typically lethal to males, and rare male survivors suffer from failure to thrive, PVNH, and severe cardiovascular and gastrointestinal complications. Here we report two surviving male siblings with a loss-of-function mutation in FLNA. They presented with multiple complications, including valvulopathy, intestinal malrotation and chronic intestinal pseudo-obstruction (CIPO). However, these siblings had atypical clinical courses, such as a lack of PVNH and a spontaneous improvement of CIPO. Trio-based whole-exome sequencing revealed a 4-bp deletion in exon 40 that was predicted to cause a lethal premature protein truncation. However, molecular investigations revealed that the mutation induced in-frame skipping of the mutated exon, which led to the translation of a mutant FLNA missing an internal region of 41 amino acids. Functional analyses of the mutant protein suggested that its binding affinity to integrin, as well as its capacity to induce focal adhesions, were comparable to those of the wild-type protein. These results suggested that exon skipping of FLNA partially restored its protein function, which could contribute to amelioration of the siblings' clinical courses. This study expands the diversity of the phenotypes associated with loss-of-function mutations in FLNA.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26059841 PMCID: PMC4755370 DOI: 10.1038/ejhg.2015.119
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246